Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Feb;282(3):445-62.
doi: 10.1111/febs.13163. Epub 2014 Dec 22.

Components and regulation of nuclear transport processes

Affiliations
Review

Components and regulation of nuclear transport processes

Bastien Cautain et al. FEBS J. 2015 Feb.

Abstract

The spatial separation of DNA replication and gene transcription in the nucleus and protein translation in the cytoplasm is a uniform principle of eukaryotic cells. This compartmentalization imposes a requirement for a transport network of macromolecules to shuttle these components in and out of the nucleus. This nucleo-cytoplasmic transport of macromolecules is critical for both cell physiology and pathology. Consequently, investigating its regulation and disease-associated alterations can reveal novel therapeutic approaches to fight human diseases, such as cancer or viral infection. The characterization of the nuclear pore complex, the identification of transport signals and transport receptors, as well as the characterization of the Ran system (providing the energy source for efficient cargo transport) has greatly facilitated our understanding of the components, mechanisms and regulation of the nucleo-cytoplasmic transport of proteins in our cells. Here we review this knowledge with a specific emphasis on the selection of disease-relevant molecular targets for potential therapeutic intervention.

Keywords: anti-cancer therapy; anti-viral therapy; karyopherins; nuclear export; nuclear import; nuclear pore complex; nuclear trafficking.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Overall structure and molecular composition of the nuclear pore complexes (NPCs). (A) General structural features of the NPC. (B) A schematic model of the NPC. In this model, the NPC is divided into several groups according to their location and structural characteristics. The symmetrical core is composed of membrane‐anchored POMS (transmembrane ring), channel Nups (central FG‐Nups) and scaffold Nups composed by adaptor Nups (inner and linker Nups) and coat Nups (outer ring). Asymmetric parts of the pore are the nuclear FG‐Nups and the basket plus the cytoplasmic FG‐Nups and filaments. (C) The yeast and vertebrate homolog Nups that are known to constitute each NPC substructure are listed. Symmetric Nups are equally distributed on the cytoplasmic and nucleoplasmic parts of the NPC and form the core region. Asymmetric Nups form the nuclear basket and the cytoplasmic filaments. They serve as docking sites for transport factors and include associated mRNA export factors. See the main text for more information.
Figure 2
Figure 2
Schematic overview of Ran‐dependent nucleo‐cytoplasmic transport. Nuclear export. CRM1 exports a great part of NES‐containing protein. Nuclear import. Importin‐α (Imp‐α)/importin‐β (Imp‐β) heterodimer (designated as α and β) and karyopherin‐β2 mediate the import of NLS‐containing proteins. See the main text for details.

References

    1. Hung MC & Link W (2011) Protein localization in disease and therapy. J Cell Sci 124, 3381–3392. - PubMed
    1. Mor A, White MA & Fontoura BM (2014) Nuclear trafficking in health and disease. Curr Opin Cell Biol 28C, 28–35. - PMC - PubMed
    1. Hill R, Cautain B, de Pedro N & Link W (2014) Targeting nucleocytoplasmic transport in cancer therapy. Oncotarget 5, 11–28. - PMC - PubMed
    1. Turner JG, Dawson J & Sullivan DM (2012) Nuclear export of proteins and drug resistance in cancer. Biochem Pharmacol 83, 1021–1032. - PMC - PubMed
    1. Turner JG & Sullivan DM (2008) CRM1‐mediated nuclear export of proteins and drug resistance in cancer. Curr Med Chem 15, 2648–2655. - PubMed

Publication types